The next generation of RAGE modulators: Implications for soluble RAGE therapies in vascular inflammation

Journal of Molecular Medicine

Volumn 91, Issue 12, 2013, Pages 1329-1331

  Bowman, Marion A Hofmann ^a   Schmidt, Ann Marie ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CALGRANULIN; CARBOHYDRATE DERIVATIVE; HIGH MOBILITY GROUP B1 PROTEIN; LYSOPHOSPHATIDIC ACID; PROTEIN S 100; RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCT; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ARTERY WALL; ATHEROSCLEROSIS; CELL ACTIVATION; CELL DAMAGE; CELL STRESS; CHO CELL; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOCOMPETENT CELL; IN-STENT RESTENOSIS; INFLAMMATORY DISEASE; INNATE IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RESTENOSIS; REVIEW; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; THORACIC AORTA ANEURYSM; VASCULITIS;

ANIMALS; ARTHRITIS; HUMANS; LIGANDS; RECEPTORS, IMMUNOLOGIC;

EID: 84890312223     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-013-1097-y     Document Type: Review

References (11)

1. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126
2. Everett BM, Pradhan AD, Solomon DH, Paynter N, Macfadyen J, Zaharris E, Gupta M, Clearfield M, Libby P, Hasan AA et al (2013) Rationale and design of the cardiovascular inflammation reduction trial: a test of the inflammatory hypothesis of atherothrombosis. Am Heart J 166:199-207, e115
3. Yan SF, Ramasamy R, Schmidt AM (2010) The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 106:842-853
4. Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, Horwood N, Nanchahal J (2012) Alarmins: awaiting a clinical response. J Clin Invest 122:2711-2719
5. Das D, Gawdzik J, Dellefave-Castillo L, McNally EM, Husain A, Raman J and Hofmann Bowman MA. (20129 S100A12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications. J Am Coll Cardiol 60: 775-785
6. Hofmann Bowman MA, Gawdzik J, Bukhari U, Husain AN, Toth PT, Kim G, Earley J, McNally EM (2011) S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program. Arterioscler Thromb Vasc Biol 31:337-344
7. -/- mice. J Clin Invest 118:183-194
8. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025-1031
9. Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B et al (2003) Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 111:959-972
10. Tae HY, Kim MJ, Park S, Tomiya N, Li G, Wei W, Petrashevskaya N, Ahmet I, Pang J, Cruschwitz S et al. (2013) The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth. J Mol Med. doi 10.1007/s00109-013-1091-4
11. Srikrishna G, Nayak J, Weigle B, Temme A, Foell D, Hazelwood L, Olsson A, Volkmann N, Hanein D, Freeze HH (2010) Carboxylated N-glycans on RAGE promote S100A12 binding and signaling. J Cell Biochem 110:645-659